Moderna mRNA1273 P403-M study Sub-protocol 2: A Phase 3b/4, Open-label Study to Assess the Immunogenicity of mRNA-1273.172 in Previously Vaccinated Adults Aged ¿18 years
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
November 18, 2024
End Date
November 17, 2025
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
November 18, 2024
End Date
November 17, 2025